1. Home
  2. AIMD vs ALUR Comparison

AIMD vs ALUR Comparison

Compare AIMD & ALUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AIMD
  • ALUR
  • Stock Information
  • Founded
  • AIMD 1984
  • ALUR 2009
  • Country
  • AIMD United States
  • ALUR United States
  • Employees
  • AIMD N/A
  • ALUR N/A
  • Industry
  • AIMD Biotechnology: Pharmaceutical Preparations
  • ALUR
  • Sector
  • AIMD Health Care
  • ALUR
  • Exchange
  • AIMD Nasdaq
  • ALUR Nasdaq
  • Market Cap
  • AIMD 16.9M
  • ALUR 16.8M
  • IPO Year
  • AIMD N/A
  • ALUR N/A
  • Fundamental
  • Price
  • AIMD $3.43
  • ALUR $2.12
  • Analyst Decision
  • AIMD
  • ALUR Strong Buy
  • Analyst Count
  • AIMD 0
  • ALUR 3
  • Target Price
  • AIMD N/A
  • ALUR $22.83
  • AVG Volume (30 Days)
  • AIMD 88.9K
  • ALUR 45.1K
  • Earning Date
  • AIMD 11-05-2025
  • ALUR 11-12-2025
  • Dividend Yield
  • AIMD N/A
  • ALUR N/A
  • EPS Growth
  • AIMD N/A
  • ALUR N/A
  • EPS
  • AIMD N/A
  • ALUR N/A
  • Revenue
  • AIMD $110,870.00
  • ALUR $19,917,000.00
  • Revenue This Year
  • AIMD N/A
  • ALUR N/A
  • Revenue Next Year
  • AIMD N/A
  • ALUR $168.27
  • P/E Ratio
  • AIMD N/A
  • ALUR N/A
  • Revenue Growth
  • AIMD 70.25
  • ALUR N/A
  • 52 Week Low
  • AIMD $2.00
  • ALUR $1.98
  • 52 Week High
  • AIMD $5.00
  • ALUR $20.00
  • Technical
  • Relative Strength Index (RSI)
  • AIMD 49.24
  • ALUR 39.60
  • Support Level
  • AIMD $3.30
  • ALUR $2.10
  • Resistance Level
  • AIMD $3.61
  • ALUR $2.23
  • Average True Range (ATR)
  • AIMD 0.26
  • ALUR 0.10
  • MACD
  • AIMD -0.06
  • ALUR 0.02
  • Stochastic Oscillator
  • AIMD 18.29
  • ALUR 33.33

About AIMD Ainos Inc.

Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.

About ALUR Allurion Technologies Inc.

Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.

Share on Social Networks: